跳至主要内容
临床试验/JPRN-jRCTs032180154
JPRN-jRCTs032180154招募中1 期

A phase I/II clinical trial of radical radiotherapy using carbon-ion beams with standard adjuvant therapy for early breast cancer - Breast Cancer II

Karasawa Kumiko0 个研究点目标入组 30 人开始时间: 2019年2月25日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
Female

入选标准

  • 1. Pathologically proven invasive ductal carcinoma or ductal carcinoma in situ.
  • 2. Tumor size <=20 mm on MRI.
  • 3. No massive LVSI or EIC.
  • 4. No lymphenode metastasis (>2 mm). Sentinel lymph node biopsy is performed prior this study.
  • 5. No distant metastasis.
  • 6. Performance status (ECOG) of 0 to 2.
  • 7. 20 years old or older.
  • 8. A life expectancy of at least 6 months.
  • 9. Written informed consent.

排除标准

  • 1. Severe complication (e.g. uncontroled lung disease, heart disease, infection, or psychiatric disease).
  • 2. Previous treatment history including surgery, chemotherapy, endocrine therapy, molecular-targeted agents for breast cancer in same side.
  • 3. Active other malignancy
  • 4. The distanse between skin surface and tumor (including EIC) <=5 mm.
  • 5. Previous radiation therapy for breast cancer in same side.
  • 6. Eligible patients for Breast cancer I or Breast cancer III.
  • 7. Pregnancy, pregnancy potential.
  • 8. Ptinents who are considered inappropriate by the attending physician due to medical, psychological or other factors.

研究者

发起方
Karasawa Kumiko

相似试验